European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 470-476 , May 2010

Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial

  • M. Kusters

      Affiliations

    • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    • Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands
    • ,
  • C.A.M. Marijnen

      Affiliations

    • Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • C.J.H. van de Velde

      Affiliations

    • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Surgery, Leiden University Medical Center, K6-R, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Tel.: +31 71 526 2309; fax: +31 71 526 6750.
    • ,
  • H.J.T. Rutten

      Affiliations

    • Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands
    • ,
  • M.J. Lahaye

      Affiliations

    • Department of Radiology, University Hospital Maastricht, Maastricht, The Netherlands
    • ,
  • J.H. Kim

      Affiliations

    • Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea
    • ,
  • R.G.H. Beets-Tan

      Affiliations

    • Department of Radiology, University Hospital Maastricht, Maastricht, The Netherlands
    • ,
  • G.L. Beets

      Affiliations

    • Department of Surgery, University Hospital Maastricht, Maastricht, The Netherlands

,Accepted 19 November 2009.

References 

  1. Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer. 2001;92(4):896–902
  2. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–646
  3. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer?. J Clin Oncol. 2008;26(2):303–312
  4. Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology. 2004;232(2):335–346
  5. Brown G. Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancer. Br J Radiol. 2005;78(2):S117–S127
  6. Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results – EORTC 22921. J Clin Oncol. 2005;23(24):5620–5627
  7. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11):2389–2430
  8. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693–701
  9. van den Brink M, Stiggelbout AM, van den Hout WB, et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol. 2004;22(19):3958–3964
  10. Zhao GP, Zhou ZG, Lei WZ, et al. Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin. World J Gastroenterol. 2005;11(3):319–322
  11. Wang Z, Zhou Z, Wang C, et al. Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis. 2005;20(3):231–237
  12. Chen W, Shen W, Chen M, et al. Study on the relationship between lymphatic vessel density and distal intramural spread of rectal cancer. Eur Surg Res. 2007;39(6):332–339
  13. Koh DM, Brown G, Temple L, et al. Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur Radiol. 2005;15(8):1650–1657
  14. Perez RO, Seid VE, Bresciani EH, et al. Distribution of lymph nodes in the mesorectum: how deep is TME necessary?. Tech Coloproctol. 2008;12(1):39–43
  15. Heald RJ, Moran BJ, Ryall RD, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133(8):894–899
  16. Kusters M, Beets GL, van de Velde CJ, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, with focus on the patterns of local recurrence. Ann Surg. 2009;249(2):229–235
  17. Salerno G, Sinnatamby C, Branagan G, et al. Defining the rectum: surgically, radiologically and anatomically. Colorectal Dis. 2006;8(Suppl. 3):5–9
  18. den Dulk M, Marijnen CA, Putter H, et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg. 2007;246(1):83–90
  19. Kusters M, Holman FA, Martijn H, et al. Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment. Radiother Oncol. 2009;92(2):221–225
  20. Holm T, Ljung A, Haggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg. 2007;94(2):232–238
  21. Valentini V, Coco C, Cellini N, et al. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys. 1999;45(5):1175–1184
  22. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23(36):9257–9264
  23. Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. Br J Cancer. 2006;94(3):351–357
  24. Steup WH, Moriya Y, van de Velde CJ. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer. 2002;38(7):911–918
  25. Moriya Y, Sugihara K, Akasu T, Fujita S. Patterns of recurrence after nerve-sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence. Dis Colon Rectum. 1995;38(11):1162–1168
  26. Mori T, Takahashi K, Yasuno M. Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg. 1998;383(6):409–415
  27. Roels S, Duthoy W, Haustermans K, et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys. 2006;65(4):1129–1142
  28. Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum. 2004;47(10):1599–1606
  29. Park JK, Kim YW, Hur H, et al. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection. Langenbecks Arch Surg. 2009;394(1):71–77

PII: S0748-7983(09)00519-8

doi: 10.1016/j.ejso.2009.11.011

European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 470-476 , May 2010

Article Tools

* Image Usage & Resolution